BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 29960041)

  • 1. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
    Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TIGIT/CD226 axis regulates human T cell function.
    Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
    J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD155T/TIGIT Signaling Regulates CD8
    He W; Zhang H; Han F; Chen X; Lin R; Wang W; Qiu H; Zhuang Z; Liao Q; Zhang W; Cai Q; Cui Y; Jiang W; Wang H; Ke Z
    Cancer Res; 2017 Nov; 77(22):6375-6388. PubMed ID: 28883004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase.
    Inozume T; Yaguchi T; Furuta J; Harada K; Kawakami Y; Shimada S
    J Invest Dermatol; 2016 Jan; 136(1):255-63. PubMed ID: 26763445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo.
    Gorczynski RM; Yu K; Clark D
    J Immunol; 2000 Nov; 165(9):4854-60. PubMed ID: 11046009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.
    Yu X; Harden K; Gonzalez LC; Francesco M; Chiang E; Irving B; Tom I; Ivelja S; Refino CJ; Clark H; Eaton D; Grogan JL
    Nat Immunol; 2009 Jan; 10(1):48-57. PubMed ID: 19011627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
    Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
    Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of inhibitory receptor TIGIT to NK cell education.
    He Y; Peng H; Sun R; Wei H; Ljunggren HG; Yokoyama WM; Tian Z
    J Autoimmun; 2017 Jul; 81():1-12. PubMed ID: 28438433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-derived CD8⁺ dendritic cells protect against acute graft-versus-host disease after experimental allogeneic bone marrow transplantation.
    Weber M; Rudolph B; Stein P; Yogev N; Bosmann M; Schild H; Radsak MP
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1696-704. PubMed ID: 25132527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT.
    Nakamura Y; Naito K; Yamashita-Kanemaru Y; Komori D; Hirochika R; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):105-109. PubMed ID: 29648914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD155-Transducing Signaling through TIGIT Plays an Important Role in Transmission of Tolerant State and Suppression Capacity.
    Negishi N; Sato T; Yamashita-Kanemaru Y; Shibuya K; Uchida K; Kametani Y; Yagita H; Kitaura J; Okumura K; Habu S
    Immunohorizons; 2018 Nov; 2(10):338-348. PubMed ID: 31022697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells.
    Seth S; Qiu Q; Danisch S; Maier MK; Braun A; Ravens I; Czeloth N; Hyde R; Dittrich-Breiholz O; Förster R; Bernhardt G
    J Biol Chem; 2011 Nov; 286(45):39153-63. PubMed ID: 21937446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
    Wu L; Mao L; Liu JF; Chen L; Yu GT; Yang LL; Wu H; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Cancer Immunol Res; 2019 Oct; 7(10):1700-1713. PubMed ID: 31387897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.
    Nguyen H; Kuril S; Bastian D; Kim J; Zhang M; Vaena SG; Dany M; Dai M; Heinrichs JL; Daenthanasanmak A; Iamsawat S; Schutt S; Fu J; Wu Y; Fairlie DP; Atkinson C; Ogretmen B; Tomlinson S; Yu XZ
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice.
    Guo Y; Zhang L; Wan S; Sun X; Wu Y; Yu XZ; Xia CQ
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1035-41. PubMed ID: 24661874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1.
    Okumura G; Abe F; Hirochika R; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):135-139. PubMed ID: 28498033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIGIT Can Exert Immunosuppressive Effects on CD8+ T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro.
    Zhang C; Wang Y; Xun X; Wang S; Xiang X; Hu S; Cheng Q; Guo J; Li Z; Zhu J
    J Immunother; 2020 Oct; 43(8):236-243. PubMed ID: 32804915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-Fc.
    Vlad G; Stokes MB; Liu Z; Chang CC; Sondermeijer H; Vasilescu ER; Colovai AI; Berloco P; D'Agati VD; Ratner L; Cortesini R; Suciu-Foca N
    Hum Immunol; 2009 Sep; 70(9):663-9. PubMed ID: 19501624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance.
    Fu W; Cai R; Ma Z; Li T; Lei C; Zhao J; Hu S
    Front Immunol; 2021; 12():649135. PubMed ID: 33841433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
    Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
    J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.